CD4 and neoplasm: We showed previously that higher levels of tumor-infiltrating CD4+ T cells and tumor-infiltrating CD8+ T cells were significantly associated with longer survival in patients with PDAC, whereas higher levels of the ratio of tumor-infiltrating FOXP3+ Tregs to CD4+ T cells were significantly associated with shorter survival [4, 5].